Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface.
The ecto-5'-nucleotidase CD73 plays an important role in the production of immune-suppressive adenosine in tumor micro-environment, and has become a validated drug target in oncology. Indeed, the anticancer immune response involves extracellular ATP to block cell proliferation through T-cell ac...
Main Authors: | Rahila Rahimova, Simon Fontanel, Corinne Lionne, Lars Peter Jordheim, Suzanne Peyrottes, Laurent Chaloin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC5805337?pdf=render |
Similar Items
-
Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
by: Franck Gallier, et al.
Published: (2011-12-01) -
Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury.
by: Cornelia Blume, et al.
Published: (2012-01-01) -
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73)
by: Elisabetta Caiazzo, et al.
Published: (2020-11-01) -
Unveiling the Role of Ecto-5′-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools
by: Marija Adzic, et al.
Published: (2018-03-01) -
Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning.
by: Georg Wolff, et al.
Published: (2015-01-01)